Lanean...
Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
Pancreatic ductal adenocarcinoma is an aggressive cancer with high recurrence rates following surgical resection. While adjuvant chemotherapy improves survival, a significant proportion of patients are unable to initiate or complete all intended therapy following pancreatectomy due to postoperative...
Gorde:
| Argitaratua izan da: | World J Gastroenterol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Baishideng Publishing Group Inc
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7002907/ https://ncbi.nlm.nih.gov/pubmed/32063686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i4.375 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|